ANDA > Nova Content
New technology could significantly decrease the cost of drug discovery, potentially leading to increased access to high-quality, personalized health care. Steven... Read More »
In the late 1990s, Novartis manufactured and patented imatinib (with the brand name Gleevec), a drug that prolongs life in patients with chronic myelogenous leukemia... Read More »
Cases in which a newly approved drug is more effective than the cheaper alternatives already available are the exceptions rather than the rule. This is the conclusion ... Read More »
‘Green’ may not be the first thing that comes to mind when thinking of pharmaceuticals, but, recently, drug companies have been committing to more... Read More »
Scientists at the Vienna University of Technology have succeeded in introducing bacterial genes into the fungus Trichoderma, enabling the fungus to produce important... Read More »
The US Food and Drug Administration (FDA) today issued three draft guidance documents on biosimilar product development to assist industry in developing these... Read More »
Shortages of key drugs used to fight infections represent a public health emergency and can put patients at risk, according to a new. Frequent anti-infective... Read More »
The American Stroke Association has been running an advertisement lately in my neighborhood that reads, “Learn to recognize a stroke, because time lost is brain ... Read More »
Bioengineers at Tufts University School of Engineering have developed a silk-based microneedle able to deliver precise drug amounts over a set time. In addition... Read More »
Researchers at Children’s Hospital Boston have created a new mathematical model that combines multiple forms of widely available data to predict adverse drug... Read More »
The more innovative you are, the more you’re worth. The 2011 salary survey published by The Scientist reported that the highest paid science careers are in... Read More »
Janssen Biotech announced today that it has negotiated an agreement with Pharmacyclics to develop and market PCI-32765, an anti-cancer compound. Janssen Biotech, a... Read More »
Pfizer Inc, and San Diego based Excaliard Pharmaceuticals, Inc, have entered into an agreement where Pfizer will privately acquire Excaliard. Pfizer said it... Read More »
CHICAGO (Reuters) - An experimental drug that chokes off the blood supply to fat cells helped obese monkeys slim down, a sign that it may work in people... Read More »
Pfizer Inc recently announced the results for the efficacy of the drug Toviaz that has been under study. The study (Study A0221048) was conducted to test... Read More »
Two major pharmaceutical companies, Amylin Pharmaceuticals Inc (“Amylin”) and Eli Lilly and Company (“Lilly”), announced today their plans to... Read More »
Abbott announced today, at the American College of Rheumatology Annual Scientific Meeting in Chicago, the results of their Phase-3 ABILITY-1 trial... Read More »
BRUSSELS (Reuters) - Belgian biotech firm Ablynx said on Friday that it had regained the rights for its TNF-Alpha targeting nanobodies from Pfizer, which... Read More »
The late 1950s saw mass prescription of a sedative called thalidomide for morning sickness. Unfortunately, it was later discovered that one enantiomer of thalidomide... Read More »
(Reuters) - U.S. health regulators approved on Friday the stroke preventer Xarelto from Bayer AG and Johnson & Johnson for people with a common heart rhythm... Read More »